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ABSTRACT An experimentally simple sequential one-pot RuAAC reaction, affording 1,5-disubstituted 
1H-1,2,3-triazoles in good to excellent yields starting from an alkyl halide, sodium azide and an alkyne, 
is reported. The organic azide is formed in situ by treating the primary alkyl halide with sodium azide in 
DMA under microwave heating. Subsequent addition of [RuClCp*(PPh3)2] and the alkyne yielded the 
desired cycloaddition product after further microwave irradiation.  
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MANUSCRIPT TEXT One of the most well known click reactions, the copper-catalyzed azide-
alkyne cycloaddition reaction (CuAAC) to form 1,4-disubstitued triazoles,1  has found numerous 
applications, not only within the organic chemistry community but also in other areas such as 
bioconjugation and materials science.2  More recently, Fokin and Jia have reported a versatile 
ruthenium-catalyzed azide-alkyne cycloaddition reaction (RuAAC) that gives access to the isomeric 
1,5-substituted triazoles, using a [RuClCp*] catalyst with different ligands either  under conventional 
heating3  or microwave conditions.4  However, applications of the RuAAC reaction are as yet less 
prevalent in comparison to the CuAAC reaction.5  Recently a mild and efficient base-catalyzed metal-
free reaction, giving access to 1,5-diaryl-substituted triazoles has also been disclosed. Despite the many 
advantages in terms of mild reaction conditions, facile isolation and purification as well as 
environmental benefits, this reaction is limited to aryl alkynes and aryl azides as substrates.6  
One restriction of organic reactions involving azides is that the selection of commercially available 
aryl and alkyl azides is limited, and also the fact that low-molecular weight organic azides, especially 
those with a low carbon-to-nitrogen ratio, are considered to be highly energetic and potentially 
explosive.7 For the CuAAC reaction, this problem has been addressed by developing one-pot 
procedures where the organic azide is generated in situ.8  However, for the RuAAC reaction affording 
1,5-disubstitued triazoles, no such convenient method has been reported. We here report a simple 
sequential one-pot procedure, starting from primary alkyl halides and sodium azide, that avoids 
handling of the neat hazardous alkyl azide. 
Initially, as a test reaction, the RuAAC reaction between benzyl azide and 3-ethynylpyridine was 
studied in different solvents under microwave heating using [RuClCp*(PPh3)2] as the catalyst, and the 
results are summarized in Table 1. Ethers like dioxane, THF and 2-MeTHF gave full conversion of the 
alkyne. In polar solvents such as DMSO, acetonitrile and water or mixtures of water with an organic 
solvent, low or only trace amounts of product were obtained. However, the use of DMA as solvent 
afforded complete consumption of the alkyne but with competing formation of dimerization by-
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products9  to a larger extent than when THF was used. However, by using two equivalents of the azide, 
this side reaction could be suppressed. Since the formation of alkyl azides from alkyl halides and 
sodium azide is normally performed in polar solvents such as DMSO, DMF or water, DMA was thus 
the obvious choice for a one-pot procedure. Fokin and Jia have reported the isolation of [RuClCp*] 
tetraazadiene complexes when an excess of the azide was used or when the azide was added to the 
catalyst before the alkyne, and found such species to be catalytically inactive.3b This was not the case 
for the substrates used in our study, however.  
Table 1. RuAAC reaction to form triazole 1 with an alkyne/azide ratio of 1:1 in different solvents. 
 
Solvent Conv. Solvent Conv. Solvent Conv. 
Dioxane ~95% DMA ~95% H2O ~5% 
THF 100% DMSO <5% THF/H2O 3:1 ~10% 
2-MeTHF 100% CH3CN ~5% CH3CN/H2O 3:1 ~5% 
      
We then explored the possibility of developing a one-pot procedure for the RuAAC starting directly 
from an alkyl halide. When benzyl bromide (2 equiv.), sodium azide (2 equiv.), 3-ethynylpyridine (1 
equiv.) and 6 mol% [RuClCp*(PPh3)2] were mixed in DMA and heated to 100 °C for 30 min in a 
microwave reactor in a one-pot procedure, only traces of product were obtained and most of the alkyne 
remained unreacted. This can be due to a side-reaction of the ruthenium catalyst with sodium azide.10 
However this problem can easily be overcome by simply running the reaction as a sequential one-pot 
procedure instead. When the alkyne and catalyst were added after the generation of the alkyl azide, full 
conversion of the alkyne to 1,5-disubstituted 1,2,3-triazole was obtained. The 1,5-substitution pattern 
was confirmed by 2D NOESY experiments. The use of [RuClCp*COD] as the catalyst was also 
investigated at several different temperatures ranging from ambient temperature to 100 °C, however the 
conversion was much lower under these conditions.  
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With this novel sequential one-pot procedure in hand (Scheme 1), the scope of the method was 
investigated with a range of different alkyl halides and alkynes. The results are summarized in Table 2.  
Scheme 1. Sequential one-pot RuAAC reaction.a 
 
     a 2.0 equiv of alkyl halide, 2.0 equiv of sodium azide and 1.0 equiv of alkyne was used. 
 
Table 2. Scope of the sequential one-pot RuAAC reaction to form 1,5-disubstituted 1,2,3-triazolesa 
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 a 2.0 equiv of alkyl halide, 2.0 equiv of sodium azide, 1.0 equiv of alkyne and 6 mol% [RuClCp*(PPh3)2] in DMA was 
used. b Conditions A: heated to 80 °C for 10 min to generate the alkyl azide and 100 °C for 30 min for the cycloaddition 
step. Conditions B: heated to 100 °C and 120 °C respectively. 
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Benzylic bromides (entries 2-5, 7 and 11) as well as other activated halides such as methyl 2-
bromoacetate (entry 1), afforded 1,5-disubstituted 1,2,3-triazoles in good to excellent yields. Aliphatic 
bromides gave slower reactions but otherwise performed well and the desired cycloaddition products 
were obtained in good yields when the temperature was increased from 80 °C to 100 °C for the first step 
and from 100 °C to 120 °C for the subsequent cyclization reaction. When the internal alkyne pent-2-yn-
1-ol was used (entry 2) a ~1:1 mixture of the two isomers was formed. This is in contrast with results 
reported by Weinreb for similar propargylic alcohols,3c where only one isomer is obtained. To 
understand if the reaction conditions used in our method gave rise to this regionselectivity, the RuAAC 
reaction between benzyl azide and pent-2-yn-1-ol catalyzed by [RuClCp*(PPh3)2] was performed in 
benzene at 100 °C for 20 min in a microwave reactor. However, the same regioisomeric ratio as 
previously was obtained, and we thus conclude that the regioselectivity is substrate dependant in this 
particular case. Small halides of low molecular weight were problematic, probably due to the instability 
and potential decomposition of the corresponding azide at the reaction temperature. However, despite 
the low boiling point of methyl azide (21 °C),11 the triazole was obtained in 18% yield when methyl 
iodide (entry 8) was used in a sealed microwave vial at 80 °C in a microwave reactor. (CAUTION! The 
reaction generating methyl azide and other small alkyl azides is potentially explosive and can be 
dangerous to scale up. The reaction should only be carried out in a microwave reactor which can 
withstand an explosion of the reaction vial.)  Primary alkyl chlorides (entries 12-14), reacted more 
slowly compared to the alkyl bromides and needed higher reaction temperatures to obtain moderate to 
excellent yields of the corresponding products. 
Secondary alkyl halides such as cyclohexyl bromide did not afford any product in our case even at 
higher temperatures, although previous reports show that secondary azides can participate in the 
cycloaddition reaction but react more slowly compared to primary azides.3b,c Another limitation is that 
the presence of acidic groups (carboxylic acid or boronic acid) in the alkyl halide or alkyne substrate, 
inhibited the reaction and no triazole product was formed in these reactions. Likewise, pyridine or 
amine functionalities in the form of the HCl- or HBr- salt present in the substrates were not tolerated. 
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Further work is in progress to investigate if the scope of the sequential one-pot reaction can be 
expanded to include also these classes of substrates. 
In summary, a simple and practical sequential one-pot method for the generation of 1,5-disubstituted 
1,2,3-triazoles has been developed. We hope this method will increase the use of the RuAAC reaction 
by enabling direct use of the more easily accessible primary halides, thus avoiding the hazardous 
handling of alkyl azides. We envision that this procedure can find many applications in the 
pharmaceutical industry for making small focused libraries of the 1,5-regioisomer, difficult to access by 
other means. 
Experimental Section 
General information: Chemicals were obtained from commercial suppliers and used without 
purification unless otherwise noted. [RuClCp*(PPh3)2] (orange solid) was purchased from Strem 
Chemicals Inc and used as such. All microwave reactions were carried out in a Biotage Series 60 
Initiator (actual vial temperature was monitored using an IR sensor), using fixed hold time. 
Abbreviations for NMR are: s, singlet; d, doublet; t, triplet; q, quartet; br s, broad singlet; app, apparent. 
Chemical shifts (δ) are given in ppm relative to the solvent residual peak (CHCl3: 7.26 ppm for 1H 
NMR and 77.23 ppm for 13C NMR and DMSO: 2.50 ppm for 1H NMR and 39.5 ppm for 13C NMR) or 
an internal standard (TMS: 0.00 ppm for 1H NMR). The 1,5-substitution pattern was confirmed for 
triazoles 5 and 9 by 2D NOESY experiments. 
General procedure for solvent investigation 
In a microwave vial were placed 3-ethynylpyridine (20.6 mg, 0.20 mmol), 6 mol% 
[RuClCp*(PPh3)2] (9.6 mg, 0.012 mmol) and solvent (3 mL). Benzyl azide (53.2 µL, 0.4 mmol) was 
added and the vial was sealed and flushed with N2 for 1-2 min. The reaction mixture was heated to 100 
°C for 30 min in a microwave reactor. The reaction was analyzed with LCMS and TLC.  
General procedure A and B 
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In a microwave vial were placed sodium azide (13.0 mg, 0.20 mmol or 26.0 mg, 0.40 mmol), alkyl 
halide (see Table 2) (0.20 mmol or 0.40 mmol) and DMA (3 mL). The reaction mixture was heated to 
80 °C (A) or 100 °C (B) for 10 min in a microwave reactor. CAUTION! The reaction generating small 
alkyl azides is potentially explosive and can be dangerous to scale up. The reaction should only be 
carried out in a microwave reactor which can withstand an explosion of the reaction vial. The vial was 
uncapped and the alkyne (0.10 mmol or 0.20 mmol) was added followed by addition of 6 mol% 
[RuClCp*(PPh3)2]. The vial was sealed and flushed with nitrogen for 1-2 min without stirring. The 
reaction mixture was heated to 100 °C (A) or 120 °C (B) for 30 min in a microwave reactor. The 
resulting product mixture was purified by flash chromatography on silica using a gradient system of 0-
30% ethyl acetate in heptane followed by 0-30% methanol in CH2Cl2. Fractions were collected using 
UV-detection at 254 and/or 280 nm to obtain the entitled product.   
3-(1-Benzyl-1H-1,2,3-triazol-5-yl)pyridine (1): Following the general procedure A using benzyl 
bromide (23.9 µL, 0.20 mmol), sodium azide (13.0 mg, 0.20 mmol) and 3-ethynylpyridine (10.3 mg, 
0.10 mmol) to obtain 3-(1-benzyl-1H-1,2,3-triazol-5-yl)pyridine (1) as a yellowish oil. Yield: 19.4 mg 
(82%). 1H NMR (400 MHz, CDCl3) δ 8.68 (br d, J = 3.8 Hz, 1H), 8.53 (br s, 1H), 7.80 (d, J = 7.6 Hz, 
1H), 7.52 (dt, J = 7.9 Hz, 1H), 7.35 (dd, J = 7.9, 4.8 Hz, 1H), 7.32 – 7.26 (m, 3H), 7.08 – 7.03 (m, 2H), 
5.57 (s, 2H). 13C NMR (101 MHz, CDCl3) δ 150.8, 149.4, 136.3, 135.1, 135.0, 134.2, 129.2, 128.6, 
127.2, 123.7, 52.3 (two aromatic signals overlap). HRMS (ESI-TOF) calculated for C14H13N4+ (M + H) 
237.1140, found 227.1148. 
Methyl 2-(5-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)acetate (2): Following the general procedure A 
using methyl 2-bromoacetate (18.9 µL, 0.20 mmol), sodium azide (13.0 mg, 0.20 mmol) and 3-
ethynylpyridine (10.3 mg, 0.10 mmol) to obtain methyl 2-(5-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)acetate 
as a brownish oil. Yield: 19.1 mg (88%). 1H NMR (400 MHz, CDCl3) δ 8.84 – 8.59 (m, 2H), 7.82 (s, 
1H), 7.76 (d, J = 7.9 Hz, 1H), 7.51 – 7.41 (m, 1H), 5.15 (s, 2H), 3.78 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 166.9, 151.1, 149.3, 136.4, 135.9, 133.9, 124.0, 123.2, 53.3, 49.3. HRMS (ESI-TOF) 
calculated for C10H11N4O2+ (M + H) 219.0882, found 219.0883. 
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(1-Benzyl-4-ethyl-1H-1,2,3-triazol-5-yl)methanol/(1-benzyl-5-ethyl-1H-1,2,3-triazol-4-
yl)methanol (3a/3b): Following the general procedure A using benzyl bromide (23.9 µL, 0.20 mmol), 
sodium azide (13.0 mg, 0.20 mmol) and pent-2-yn-1-ol (8.4 mg, 0.10 mmol) to obtain a ~1:1 mixture of 
the regioisomers of 3 as a yellowish-brown oil. Yield: 18.4 mg (85%). 1H NMR (400 MHz, CDCl3) δ 
7.37 – 7.12 (m, 5H), 5.58 (s, minor isomer) and 5.48 (s, major isomer, 2H), 4.70 (s, major isomer) and 
4.55 (s, minor isomer, 2H), 3.52 (br s, minor isomer) and 3.08 (br s, major isomer, 1H), 2.63 (q, J = 7.6 
Hz, 2H), 1.23 (t, J = 7.6 Hz, minor isomer) and 1.03 (t, J = 7.6 Hz, major isomer, 3H). 13C NMR (151 
MHz, CDCl3) δ 147.9, 144.6, 136.5, 135.4, 135.2, 131.6, 129.2, 129.1, 128.6, 128.5, 127.7, 127.3, 56.1, 
52.5, 52.3, 52.1, 18.5, 16.3, 14.5, 13.5. HRMS (ESI-TOF) calculated for C12H16N3O+ (M + H) 
218.1293, found 218.1297. 
1-(3-Methoxybenzyl)-5-(1-methyl-1H-imidazol-5-yl)-1H-1,2,3-triazole (4): Following the general 
procedure A using 1-(bromomethyl)-3-methoxybenzene (28.0 µL, 0.20 mmol), sodium azide (13.0 mg, 
0.20 mmol) and 5-ethynyl-1-methyl-1H-imidazole (10.2 µL, 0.10 mmol) to obtain 1-(3-
methoxybenzyl)-5-(1-methyl-1H-imidazol-5-yl)-1H-1,2,3-triazole (4) as a yellowish oil. Yield: 25.0 mg 
(93%). 1H NMR (400 MHz, CDCl3) δ 7.75 (s, 1H), 7.55 (br s, 1H), 7.19 (t, J = 7.8 Hz, 1H), 7.11 (br s, 
1H), 6.82 (dd, J = 8.4, 2.3 Hz, 1H), 6.61 – 6.53 (m, 2H), 5.46 (s, 2H), 3.71 (s, 3H), 3.16 (s, 3H). 13C 
NMR (151 MHz, CDCl3) δ 160.1, 140.4, 136.4, 135.2, 131.8, 130.1, 126.6, 119.8, 118.4, 114.4, 112.9, 
55.4, 52.4, 31.9. HRMS (ESI-TOF) calculated for C14H16N5O+ (M + H) 270.1355, found 270.1357. 
Di-tert-butyl ((1,1'-(naphthalene-2,6-diylbis(methylene))bis(1H-1,2,3-triazole-5,1-diyl))bis-
(methylene))dicarbamate (5): Following the general procedure A using 2,6-bis(bromomethyl)-
naphthalene (62.8 mg, 0.20 mmol) and tert-butyl prop-2-yn-1-ylcarbamate (31.0 mg, 0.20 mmol) to 
obtain di-tert-butyl ((1,1'-(naphthalene-2,6-diylbis(methylene))bis(1H-1,2,3-triazole-5,1-diyl))bis-
(methylene)) dicarbamate (5) as an off-white solid. Yield: 57.0 mg (52%, purity 96%). 1H NMR (800 
MHz, DMSO-d6) δ 7.85 (d, J = 8.5 Hz, 2H), 7.68 (s, 2H), 7.55 (s, 2H), 7.48 – 7.44 (m, 2H), 7.33 (d, J = 
8.4 Hz, 2H), 5.75 (s, 4H), 4.18 (d, J = 5.2 Hz, 4H), 1.29 (s, 18H). 13C NMR (151 MHz, DMSO-d6) δ 
155.5, 136.0, 133.7, 132.8, 132.2, 128.5, 125.9, 125.8, 78.4, 50.6, 32.9, 28.0. HRMS (ESI-TOF) 
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calculated for C28H37N8O4+ (M + H) 549.2938, found 549.2943. The 1,5-substitution pattern was 
confirmed by a 2D NOESY experiment. 
5-(1-Methyl-1H-imidazol-5-yl)-1-(4-phenoxybutyl)-1H-1,2,3-triazole (6): Following the general 
procedure B using (4-bromobutoxy)benzene (106.0 mg, 0.46 mmol), sodium azide (13.0 mg, 0.20 
mmol) and 5-ethynyl-1-methyl-1H-imidazole (20.4 µL, 0.2 mmol) to obtain 5-(1-methyl-1H-imidazol-
5-yl)-1-(4-phenoxybutyl)-1H-1,2,3-triazole (6) as a brownish oil. Yield: 41.7 mg (70%). 1H NMR (400 
MHz, CDCl3) δ 7.74 (s, 1H), 7.64 (s, 1H), 7.31 – 7.19 (m, 3H), 6.95 – 6.91 (m, 1H), 6.83 (d, J = 8.3 Hz, 
2H), 4.39 (t, J = 7.1 Hz, 2H), 3.93 (t, J = 5.9 Hz, 2H), 3.55 (s, 3H), 2.10 – 2.01 (m, 2H), 1.82 – 1.72 (m, 
2H). 13C NMR (151 MHz, CDCl3) δ 158.8, 140.6, 134.4, 131.6, 129.6, 126.5, 121.0, 118.7, 114.5, 66.8, 
48.3, 32.4, 27.2, 26.4. HRMS (ESI-TOF) calculated for C16H20N5O+ (M + H) 298.1668, found 
298.1673. 
5-(3-Chloropropyl)-1-(naphthalen-2-ylmethyl)-1H-1,2,3-triazole (7): Following the general 
procedure A using 2-(bromomethyl)naphthalene (45.1 mg, 0.20 mmol, purified by flash 
chromatography), sodium azide (13.0 mg, 0.20 mmol) and 5-chloropent-1-yne (10.7 µL, 0.1 mmol) to 
obtain 5-(3-chloropropyl)-1-(naphthalen-2-ylmethyl)-1H-1,2,3-triazole (7) as a brownish oil. Yield: 
16.7 mg (58%, purity 93%). 1H NMR (400 MHz, CDCl3) δ 7.86 – 7.76 (m, 3H), 7.60 (s, 1H), 7.54 (s, 
1H), 7.52 – 7.47 (m, 2H), 7.32 – 7.25 (m, 1H), 5.70 (s, 1H), 3.46 (t, J = 6.0 Hz, 1H), 2.74 (t, J = 7.6 Hz, 
2H), 1.98 – 1.90 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 136.1, 133.4, 133.2, 133.1, 132.4, 129.3, 
128.1, 128.0, 126.9, 126.8, 126.4, 124.8, 52.2, 43.7, 30.7, 20.5. HRMS (ESI-TOF) calculated for 
C16H17ClN3+ (M + H) 286.1111, found 286.1114. 
3-(1-Methyl-1H-1,2,3-triazol-5-yl)pyridine (8): Following the general procedure A, but was not 
flushed with nitrogen after catalyst addition, using iodomethane (12.5 µL, 0.20 mmol), sodium azide 
(13.0 mg, 0.20 mmol) and 3-ethynylpyridine (10.3 mg, 0.10 mmol) to obtain 3-(1-benzyl-1H-1,2,3-
triazol-5-yl)pyridine (8) as a brownish oil. Yield: 2.9 mg (18%). 1H NMR (400 MHz, CDCl3) δ 9.04 (br 
s, 1H), 8.65 (br s, 1H), 8.22 (d, J = 7.5 Hz, 1H), 7.84 (s, 1H), 7.41 (br s, 1H), 4.19 (s, 3H). 13C NMR 
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(151 MHz, CDCl3) δ 149.5, 147.3, 133.2, 132.3, 124.0, 121.1, 37.1 (two aromatic signals overlap). 
HRMS (ESI-TOF) calculated for C8H9N4+ (M + H) 161.0827, found 161.0835. 
1-Isopentyl-5-((phenylthio)methyl)-1H-1,2,3-triazole (9): Following the general procedure B using 
1-bromo-3-methylbutane (49.9 µL, 0.40 mmol), sodium azide (26.0 mg, 0.40 mmol) and phenyl(prop-2-
yn-1-yl)sulfane (28.4 µL, 0.20 mmol) to obtain 1-isopentyl-5-((phenylthio)methyl)-1H-1,2,3-triazole (9) 
as a yellowish-brown oil. Yield: 38.1 mg (73%). 1H NMR (400 MHz, CDCl3) δ 7.33 (s, 1H), 7.32 – 7.27 
(m, 5H), 4.32 – 4.24 (m, 2H), 4.06 (s, 2H), 1.83 – 1.75 (m, 2H), 1.68 – 1.59 (m, 1H), 0.97 (d, J = 6.6 
Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 133.9, 133.5, 132.7, 132.2, 129.4, 128.2, 46.6, 38.8, 27.5, 25.9, 
22.4. HRMS (ESI-TOF) calculated for C14H20N3S+ (M + H) 262.1378, found 262.1384. The 1,5-
substitution pattern was confirmed by a 2D NOESY experiment. 
2-(2-(5-Phenyl-1H-1,2,3-triazol-1-yl)ethyl)isoindoline-1,3-dione (10): Following the general 
procedure B using 2-(2-bromoethyl)isoindoline-1,3-dione (112.9 mg, 0.40 mmol), sodium azide (26.0 
mg, 0.40 mmol) and ethynylbenzene (22.4 µL, 0.20 mmol) to obtain 2-(2-(5-phenyl-1H-1,2,3-triazol-1-
yl)ethyl)isoindoline-1,3-dione (10) as a yellow oil. Yield: 58.5 mg (92%). 1H NMR (400 MHz, CDCl3) 
δ 7.75 – 7.68 (m, 4H), 7.65 (s, 1H), 7.36 (s, 5H), 4.76 – 4.72 (m, 2H), 4.01 – 3.96 (m, 2H). 13C NMR 
(101 MHz, CDCl3) δ 167.6, 138.2, 134.2, 133.5, 131.8, 129.6, 129.2, 128.8, 126.7, 123.5, 46.2, 37.8. 
HRMS (ESI-TOF) calculated for C18H15N4O2+ (M + H) 319.1195, found 319.1209. 
5-(4-Fluorophenyl)-1-(2-nitrobenzyl)-1H-1,2,3-triazole (11): Following the general procedure A 
using 1-(bromomethyl)-2-nitrobenzene (86.4 mg, 0.40 mmol, purified by flash chromatography), 
sodium azide (26.0 mg, 0.40 mmol) and 1-ethynyl-4-fluorobenzene (23.2 µL, 0.20 mmol) to obtain 5-
(4-fluorophenyl)-1-(2-nitrobenzyl)-1H-1,2,3-triazole (11) as an off-white solid. Yield: 54.6 mg (92%). 
1H NMR (400 MHz, CDCl3) δ 8.16 (dd, J = 8.1, 1.4 Hz, 1H), 7.82 (s, 1H), 7.60 (td, J = 4.6, 2.3 Hz, 1H), 
7.52 (td, J = 8.1, 1.4 Hz, 1H), 7.26 – 7.20 (m, 2H), 7.14 – 7.08 (m, 2H), 6.80 (dd, J = 7.7, 0.9 Hz, 1H), 
5.97 (s, 2H). 13C NMR (101 MHz, CDCl3) δ 163.6 (d, 1JCF = 251.2 Hz), 147.0, 138.1, 134.6, 133.6, 
131.8, 130.6 (d, 3JCF = 8.5 Hz), 129.4, 128.8, 125.6, 122.5 (d, 4JCF = 3.5 Hz), 116.7 (d, 2JCF = 22.0 Hz), 
49.2. HRMS (ESI-TOF) calculated for C15H12FN4O2+ (M + H) 299.0944, found 299.0943. 
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5-(1-Methyl-1H-imidazol-5-yl)-1-(3-phenylpropyl)-1H-1,2,3-triazole (12): Following the general 
procedure B using (3-chloropropyl)benzene (57.9 µL, 0.40 mmol), sodium azide (26.0 mg, 0.40 mmol) 
and 5-ethynyl-1-methyl-1H-imidazole (20.4 µL, 0.2 mmol) to obtain 5-(1-methyl-1H-imidazol-5-yl)-1-
(3-phenylpropyl)-1H-1,2,3-triazole (12) as a brownish oil. Yield: 25.2 mg (47 %). 1H NMR (400 MHz, 
CDCl3) δ 7.75 (s, 1H), 7.64 (s, 1H), 7.31 – 7.25 (m, 2H), 7.23 – 7.18 (m, 1H), 7.16 – 7.11 (m, 3H), 4.31 
(t, J = 7.3 Hz, 2H), 3.54 (s, 3H), 2.65 (t, J = 7.6 Hz, 2H), 2.23 – 2.14 (m, 2H). 13C NMR (101 MHz, 
CDCl3) δ 140.4, 140.1, 134.2, 131.4, 128.7, 128.4, 126.5, 126.4, 118.5, 47.8, 32.6, 32.3, 31.6. HRMS 
(ESI-TOF) calculated for C15H18N5+ (M + H) 268.1562, found 268.1562. 
1-Benzyl-5-(4-fluorophenyl)-1H-1,2,3-triazole (13): Following the general procedure B using 
benzyl chloride (46.5 µL, 0.40 mmol), sodium azide (26.0 mg, 0.40 mmol) and 1-ethynyl-4-
fluorobenzene (23.2 µL, 0.20 mmol) to obtain 1-benzyl-5-(4-fluorophenyl)-1H-1,2,3-triazole (13) as a 
yellowish oil. Yield: 49.1 mg (97%). 1H NMR (400 MHz, CDCl3) δ 7.71 (s, 1H), 7.31 – 7.26 (m, 3H), 
7.24 – 7.18 (m, 2H), 7.13 – 7.08 (m, 2H), 7.08 – 7.04 (m, 2H), 5.52 (s, 2H). 13C NMR (101 MHz, 
CDCl3) δ 163.5 (d, 1JCF = 250.4 Hz), 137.3, 135.5, 133.6, 131.1 (d, 3JCF = 8.5 Hz), 129.0, 128.4, 127.2, 
123.1 (d, 4JCF = 3.5 Hz), 116.3 (d, 2JCF = 21.9 Hz), 52.0. HRMS (ESI-TOF) calculated for C15H13FN3+ 
(M + H) 254.1093, found 254.1083. 
2-(1-(3-(Trifluoromethyl)benzyl)-1H-1,2,3-triazol-5-yl)pyridine (14): Following the general 
procedure B using 1-(chloromethyl)-3-(trifluoromethyl)benzene (60.8 µL, 0.40 mmol), sodium azide 
(26.0 mg, 0.40 mmol) and 2-ethynylpyridine (20.6 µL, 0.20 mmol) to obtain 2-(1-(3-
(trifluoromethyl)benzyl)-1H-1,2,3-triazol-5-yl)pyridine (14) as a yellowish oil. Yield: 37.4 mg (61%, 
purity 99%). 1H NMR (400 MHz, CDCl3) δ 8.69 – 8.66 (m, 1H), 8.04 (s, 1H), 7.78 – 7.72 (m, 1H), 7.60 
– 7.56 (m, 2H), 7.50 – 7.43 (m, 2H), 7.37 (t, J = 7.7 Hz, 1H), 7.31 – 7.27 (m, 1H), 6.21 (s, 2H). 13C 
NMR (101 MHz, CDCl3) δ 149.6, 146.8, 137.4, 137.2, 135.7, 133.8, 131.5 (q, 4JCF = 1.3 Hz), 130.9 
(app d, 2JCF = 32.4 Hz), 129.2, 125.2 (q, 3JCF = 3.9 Hz), 124.9 (q, 3JCF = 3.8 Hz), 124.0 (app d, 1JCF = 
272.3 Hz), 123.7, 122.9, 52.9. HRMS (ESI-TOF) calculated for C15H12F3N4+ (M + H) 305.1014, found 
305.1009. 
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